Crescent Capital BDC, Inc. (NASDAQ:CCAP) Given Average Recommendation of "Moderate Buy" by Analysts

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $19.17.

CCAP has been the topic of several research analyst reports. Keefe, Bruyette & Woods upped their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Monday, November 25th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They set a "buy" rating and a $20.00 price target for the company.

Institutional Investors Weigh In On Crescent Capital BDC

Hedge funds and other institutional investors have recently modified their holdings of the company. Confluence Investment Management LLC grew its stake in shares of Crescent Capital BDC by 0.9% in the fourth quarter. Confluence Investment Management LLC now owns 73,839 shares of the company's stock valued at $1,419,000 after acquiring an additional 633 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Crescent Capital BDC by 0.5% in the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock valued at $2,624,000 after purchasing an additional 768 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth approximately $90,000. XTX Topco Ltd bought a new position in shares of Crescent Capital BDC during the second quarter worth approximately $195,000. Finally, Pettinga Financial Advisors LLC raised its position in shares of Crescent Capital BDC by 95.8% in the third quarter. Pettinga Financial Advisors LLC now owns 29,017 shares of the company's stock valued at $537,000 after buying an additional 14,200 shares in the last quarter. Institutional investors and hedge funds own 49.46% of the company's stock.

Crescent Capital BDC Stock Performance

Shares of Crescent Capital BDC stock traded down $0.02 during trading on Wednesday, hitting $18.80. 103,775 shares of the stock were exchanged, compared to its average volume of 106,475. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. The company has a fifty day moving average price of $19.15 and a 200-day moving average price of $18.76. The stock has a market capitalization of $696.77 million, a price-to-earnings ratio of 7.37 and a beta of 0.81. Crescent Capital BDC has a 1-year low of $15.91 and a 1-year high of $20.03.

Crescent Capital BDC Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.42 per share. This is a boost from Crescent Capital BDC's previous quarterly dividend of $0.07. This represents a $1.68 annualized dividend and a yield of 8.94%. The ex-dividend date of this dividend is Tuesday, December 31st. Crescent Capital BDC's dividend payout ratio (DPR) is presently 65.88%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.